Skip to main content
. 2012 May 30;120(8):1581–1588. doi: 10.1182/blood-2012-02-408336

Figure 4.

Figure 4

Relapse risk and relapse-free survival by residual disease (RD) status at the end of induction 2. Relapse risk and relapse-free survival by residual disease status at the end of induction 2 (A-B) and at the end of therapy (C-D).